Skip to main content
. 2006 Jul 18;24(49):7056–7065. doi: 10.1016/j.vaccine.2006.07.009
Dr. Larry J. Anderson, Chief, Respiratory and Enteric Viruses Branch, Centers for Disease Control and Prevention, USA
Dr. Tracey Baas, Katze Laboratory, University of Washington, USA
*Dr. Lorne Allan Babiuk (could not attend), Vaccine & Infectious Disease Organization (VIDO), University of Saskatchewan, Canada
Professor Jianshi Bai, Deputy Director, Division of Blood Products, National Institute for the Control of Pharmaceutical and Biological Products, People's Republic of China
*Dr. Ralph Baric (could not attend), University of North Carolina, USA
Dr. Frederick J. Cassels, SARS Program Officer, RDB/DMID/NIAID/NIH/DHHS, USA
Dr. Thomas Cherian, Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Switzerland
Dr. Markus Czub, Canadian Science Centre for Human and Animal Health, Canada
Dr. Rose Das, National Institute for Biological Standards and Control, United Kingdom
Professor Guanmu Dong, Director, First Division of Viral Vaccines, National Institute for the Control of Pharmaceutical & Biological Products, People's Republic of China
Dr. Morag Ferguson, Senior Virologist, National Institute of Biological Standards and Control, United Kingdom
*Dr. Reinhard Glueck (could not attend), Berna Biotech AG, Switzerland
Dr. Bart Haagmans, Institute of Virology, Erasmus Medical Centre, The Netherlands
*Dr. Wei He (could not attend), Deputy Director, Peking Union Medical College, People's Republic of China
*Dr. Stephen L. Hoffmann (could not attend), Chief Executive and Scientific Officer, Sanaria Inc., USA
Dr. Harvey Holmes, National Institute for Biological Standards and Control (NIBSC), United Kingdom
Dr. Katja Hoschler, Clinical Scientist, Health Protection Agency, United Kingdom
Dr. Koji Ishii, Department of Virology, National Institute of Infectious Diseases, Japan
*Dr. Steven Jones (could not attend), Special Pathogens Program, Health Canada, Canada
Dr. Colleen Jonsson, Homeland Security and Infectious Diseases, Southern Research Institute, USA
*Dr. Marie-Paule Kieny (could not attend), Director, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
*Dr. Otfried Kistner (could not attend), Director Virology, Baxter BioScience, Austria
Dr. Diane Major, National Institute for Biological Standards and Control, United Kingdom
Dr. Keith Mansfield, Chair of the Division of Primate Resources, New England Primate Research Center (NEPRC), USA
Dr. Gary J. Nabel, Director, Vaccine Research Center, NIAID/NIH, USA
Dr. Albert Osterhaus, Head of the Department of Virology, Erasmus University, The Netherlands
Professor Chuan Qin, Director, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, People's Republic of China
Peter Rigsby, National Institute for Biological Standards and Control, United Kingdom
Dr. Anjeanette Roberts, Staff Scientist, Laboratory of Infectious Diseases, NIAID/NIH, USA
Professor P.J.M. Rottier, Utrecht University, Faculty of Veterinary Medicine, The Netherlands
Dr. Jean-François Saluzzo, Chief, Viral Vaccines Production, Sanofi Pasteur SA, France
*Dr. Quentin Sattentau (could not attend), The Sir William Dunn School of Pathology, University of Oxford, United Kingdom
Dr. Martin Spruth, Manager, Viral Vaccines, Baxter BioScience, Austria
Dr. Konrad Stadler, Virologist, International Federation of Pharmaceutical Manufacturers Association (IFPMA), Chiron SpA, Italy
Dr. Kanta Subbarao, Senior Investigator, Laboratory of Infectious Diseases, NIAID/NIH, USA
*Dr. Fumihiro Taguchi (could not attend), Chief, Laboratory of acute viral respiratory infections, Japan
Dr. Deborah R. Taylor, Chair, Emerging Infectious Diseases Working Group, CBER FDA, USA
Dr. Hana Weingartl, National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Canada
Dr. Patrick C.Y. Woo, Associate Professor, Department of Microbiology, The University of Hong Kong, People's Republic of China
Dr. David Wood, Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Switzerland
Dr. John Wood, Division of Virology, National Institute for Biological Standards & Control, United Kingdom
Dr. Zhiwei Yang, Director, Department of Research and Development, Chinese Academy of Medical Sciences and Peking Union Medical College, People's Republic of China
Professor Hongzhang Yin, Director, Division of Biological Products, State Food and Drug Administration (SFDA), People's Republic of China
*Dr. Maria Zambon (could not attend), Virus Reference Division, Health Protection Agency, United Kingdom